To the Editor—The updated clinical practice guidelines on Clostridium difficile infection (CDI) [1] for the Infectious Diseases Society of America and Society for Healthcare Epidemiology of America is a valuable document for clinicians and researchers, summarizing the current evidence for diagnosis, surveillance, and management of CDI. Despite concerted efforts worldwide to control the spread of C. difficile, it not only remains the primary cause of healthcare-associated diarrhea, but it is also an important pathogen in the community. Thus, it is vital that we continuously monitor and improve our management and control of CDI.

中文翻译：

---

艰难梭菌指南

致编辑—美国传染病学会和美国医疗卫生流行病学会关于艰难梭菌感染（CDI）的最新临床实践指南[1]对于临床医生和研究人员而言是一份有价值的文件，总结了当前的诊断，监测证据。 ，以及CDI的管理。尽管在全球范围内共同努力控制艰难梭菌的传播，但它不仅仍然是医疗保健相关的腹泻的主要原因，而且还是社区中的重要病原体。因此，至关重要的是，我们要持续监控和改进对CDI的管理和控制。